Clinical Trial Update: Maintenance Treatment of Chidamide in Stage IV or Relapsed/Refractory Extranodal NK/T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating maintenance chidamide for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma (nasal type).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Natural Killer T-cell Lymphoma Nasal Type

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Phase 2 | Status: UNKNOWN